Fleury (BSP:FLRY3) Short Interest


BSP:FLRY3 Fleury SA BSP:FLRY3
91 GF Score
Price R$15.61
GF Value R$17.41
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Fleury Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BSP:FLRY3 vs TMO, DHR, IDXX: Short Interest Comparison

For the Diagnostics & Research subindustry, Fleury's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fleury Short Interest vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Fleury's Short Interest distribution charts can be found below:

* The bar in red indicates where Fleury's Short Interest falls into.


BSP:FLRY3
91GF Score
Fleury SA BSP:FLRY3
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fleury (BSP:FLRY3) Overvalued in 2026?

Based on GuruFocus' analysis, Fleury stock appears to be undervalued. The current stock price of R$15.61 is trading 10.3% below its estimated GF Value™ of R$17.41. GuruFocus considers Fleury to be Modestly Undervalued.

Key valuation signals for BSP:FLRY3:

  • Short Interest:
  • GF Value™: R$17.41 vs. price of R$15.61 (10.3% below fair value)
  • GF Score™: 91/100 with 4 warning signs

No single metric tells the full story. See the BSP:FLRY3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fleury Business Description

Address Avenida Morumbi 8.860, 8th floor, Brooklin, Sao Paulo, SP, BRA, 04703-002
Fleury SA is engaged in the provision of medical services in the diagnostic, laboratory support (Lab-to-Lab), infusions, clinical analysis, health management, medical care, orthopedics and ophthalmology, fertility, infusion areas and toxicological exams, among others. The company offers diagnostic medicine through physical service units and mobile diagnostic services for consumers. It also provides diagnostic support services to laboratories and hospitals. In addition, the company operates clinics and services in areas such as infusion therapy, orthopedics, ophthalmology, reproductive medicine, and oncology. It has two reportable business segments: Diagnostic Medicine and Integrated Medicine. The maximum revenue is generated from the Diagnostic Medicine Segment.
91GF Score

Get the complete analysis for BSP:FLRY3

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$15.61
Price
R$17.41
GF Value